73 related articles for article (PubMed ID: 18813841)
1. Prediction of doxorubicin sensitivity in gastric cancers based on a set of novel markers.
Liu H; Li N; Yao L; Jiang L; Bao G; Li J; Ma Q; Liu Z
Oncol Rep; 2008 Oct; 20(4):963-9. PubMed ID: 18813841
[TBL] [Abstract][Full Text] [Related]
2. Prediction of doxorubicin sensitivity in breast tumors based on gene expression profiles of drug-resistant cell lines correlates with patient survival.
Györffy B; Serra V; Jürchott K; Abdul-Ghani R; Garber M; Stein U; Petersen I; Lage H; Dietel M; Schäfer R
Oncogene; 2005 Nov; 24(51):7542-51. PubMed ID: 16044152
[TBL] [Abstract][Full Text] [Related]
3. Prediction of response to neoadjuvant chemotherapy for osteosarcoma by gene-expression profiles.
Ochi K; Daigo Y; Katagiri T; Nagayama S; Tsunoda T; Myoui A; Naka N; Araki N; Kudawara I; Ieguchi M; Toyama Y; Toguchida J; Yoshikawa H; Nakamura Y
Int J Oncol; 2004 Mar; 24(3):647-55. PubMed ID: 14767549
[TBL] [Abstract][Full Text] [Related]
4. Prediction of recurrence-free survival in postoperative non-small cell lung cancer patients by using an integrated model of clinical information and gene expression.
Lee ES; Son DS; Kim SH; Lee J; Jo J; Han J; Kim H; Lee HJ; Choi HY; Jung Y; Park M; Lim YS; Kim K; Shim Y; Kim BC; Lee K; Huh N; Ko C; Park K; Lee JW; Choi YS; Kim J
Clin Cancer Res; 2008 Nov; 14(22):7397-404. PubMed ID: 19010856
[TBL] [Abstract][Full Text] [Related]
5. Gene expression based classification of gastric carcinoma.
Nørsett KG; Laegreid A; Midelfart H; Yadetie F; Erlandsen SE; Falkmer S; Grønbech JE; Waldum HL; Komorowski J; Sandvik AK
Cancer Lett; 2004 Jul; 210(2):227-37. PubMed ID: 15183539
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profile predicts patient survival of gastric cancer after surgical resection.
Chen CN; Lin JJ; Chen JJ; Lee PH; Yang CY; Kuo ML; Chang KJ; Hsieh FJ
J Clin Oncol; 2005 Oct; 23(29):7286-95. PubMed ID: 16145069
[TBL] [Abstract][Full Text] [Related]
7. A candidate molecular signature associated with tamoxifen failure in primary breast cancer.
Vendrell JA; Robertson KE; Ravel P; Bray SE; Bajard A; Purdie CA; Nguyen C; Hadad SM; Bieche I; Chabaud S; Bachelot T; Thompson AM; Cohen PA
Breast Cancer Res; 2008; 10(5):R88. PubMed ID: 18928543
[TBL] [Abstract][Full Text] [Related]
8. Gene expression analysis of diagnostic biopsies predicts pathological response to neoadjuvant chemoradiotherapy of esophageal cancer.
Maher SG; Gillham CM; Duggan SP; Smyth PC; Miller N; Muldoon C; O'Byrne KJ; Sheils OM; Hollywood D; Reynolds JV
Ann Surg; 2009 Nov; 250(5):729-37. PubMed ID: 19801928
[TBL] [Abstract][Full Text] [Related]
9. Microarray-based prediction of tumor response to neoadjuvant radiochemotherapy of patients with locally advanced rectal cancer.
Rimkus C; Friederichs J; Boulesteix AL; Theisen J; Mages J; Becker K; Nekarda H; Rosenberg R; Janssen KP; Siewert JR
Clin Gastroenterol Hepatol; 2008 Jan; 6(1):53-61. PubMed ID: 18166477
[TBL] [Abstract][Full Text] [Related]
10. In vitro pharmacogenomic database and chemosensitivity predictive genes in gastric cancer.
Jung JJ; Jeung HC; Chung HC; Lee JO; Kim TS; Kim YT; Noh SH; Rha SY
Genomics; 2009 Jan; 93(1):52-61. PubMed ID: 18804159
[TBL] [Abstract][Full Text] [Related]
11. The results of the expression array studies correlate and enhance the known genetic basis of gastric and colorectal cancer.
Galamb O; Sipos F; Fischer K; Tulassay Z; Molnar B
Cytometry B Clin Cytom; 2005 Nov; 68(1):1-17. PubMed ID: 16208682
[TBL] [Abstract][Full Text] [Related]
12. Survivin expression in gastric cancer: Association with histomorphological response to neoadjuvant therapy and prognosis.
Vallböhmer D; Drebber U; Schneider PM; Baldus S; Bollschweiler E; Brabender J; Warnecke-Eberz U; Mönig S; Hölscher AH; Metzger R
J Surg Oncol; 2009 Jun; 99(7):409-13. PubMed ID: 19347901
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
[TBL] [Abstract][Full Text] [Related]
14. Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis.
Hu H; Sun L; Guo C; Liu Q; Zhou Z; Peng L; Pan J; Yu L; Lou J; Yang Z; Zhao P; Ran Y
Clin Cancer Res; 2009 Sep; 15(17):5485-93. PubMed ID: 19706805
[TBL] [Abstract][Full Text] [Related]
15. microRNA expression profile in undifferentiated gastric cancer.
Katada T; Ishiguro H; Kuwabara Y; Kimura M; Mitui A; Mori Y; Ogawa R; Harata K; Fujii Y
Int J Oncol; 2009 Feb; 34(2):537-42. PubMed ID: 19148490
[TBL] [Abstract][Full Text] [Related]
16. A potential role of collagens expression in distinguishing between premalignant and malignant lesions in stomach.
Zhao Y; Zhou T; Li A; Yao H; He F; Wang L; Si J
Anat Rec (Hoboken); 2009 May; 292(5):692-700. PubMed ID: 19306436
[TBL] [Abstract][Full Text] [Related]
17. Concise prediction models of anticancer efficacy of 8 drugs using expression data from 12 selected genes.
Tanaka T; Tanimoto K; Otani K; Satoh K; Ohtaki M; Yoshida K; Toge T; Yahata H; Tanaka S; Chayama K; Okazaki Y; Hayashizaki Y; Hiyama K; Nishiyama M
Int J Cancer; 2004 Sep; 111(4):617-26. PubMed ID: 15239142
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide expression profile of sporadic gastric cancers with microsatellite instability.
D'Errico M; de Rinaldis E; Blasi MF; Viti V; Falchetti M; Calcagnile A; Sera F; Saieva C; Ottini L; Palli D; Palombo F; Giuliani A; Dogliotti E
Eur J Cancer; 2009 Feb; 45(3):461-9. PubMed ID: 19081245
[TBL] [Abstract][Full Text] [Related]
19. Grade-dependent effects on cell cycle progression and apoptosis in response to doxorubicin in human bladder cancer cell lines.
Stravopodis DJ; Karkoulis PK; Konstantakou EG; Melachroinou S; Lampidonis AD; Anastasiou D; Kachrilas S; Messini-Nikolaki N; Papassideri IS; Aravantinos G; Margaritis LH; Voutsinas GE
Int J Oncol; 2009 Jan; 34(1):137-60. PubMed ID: 19082486
[TBL] [Abstract][Full Text] [Related]
20. Identifying patients at high risk for neutropenic complications during chemotherapy for metastatic breast cancer with doxorubicin or pegylated liposomal doxorubicin: the development of a prediction model.
Dranitsaris G; Rayson D; Vincent M; Chang J; Gelmon K; Sandor D; Reardon G
Am J Clin Oncol; 2008 Aug; 31(4):369-74. PubMed ID: 18845996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
